Zinereo Pharma®, a company within the Spanish biotechnology group ZENDAL, develops and manufactures innovative probiotic solutions under GMP standards, transforming Microbiome Science into solutions across multiple health areas.
LATEST NEWS
Key Areas
EVERYTHING STARTS IN THE GUT AND IMPACTS MULTIPLE BIOLOGICAL AXES
Salud de la Mujer
Soluciones basadas en la ciencia del microbioma para la salud de la mujer a lo largo de su ciclo vital
Rendimiento Deportivo
Soluciones probióticas personalizadas para todo tipo de entrenamientos
Veterinaria
Soluciones postbióticas como coadyuvantes para ayudar a reducir los signos de la Dermatitis Atópica Canina (DAC)
Salud Intestinal e Inmunológica
Soluciones basadas en la ciencia del microbioma para favorecer la función intestinal y fortalecer la salud inmunológica
Modal Box Title
Efficacy
Quality
Safety
Our key drivers are efficacy, quality, and safety translated by products manufactured under pharmaceutical GMP standards.
Clinical Trials
Registered patents
Developed with science
Manufactured in EU
Good Manufacturing Practice
life for LIFE
Our mission is rooted in the principle of ‘life for LIFE’.
By leveraging microscopic life forms such as probiotic microorganisms, we can significantly impact all life forms, human health, animal health and the planet.
Providing life to improve our own LIFE
Quality Pharma Probiotics
By leveraging microbiome expertise, we offer innovative probiotic solutions across pharmaceutical, nutraceutical and veterinary sectors to enhance human and animal health.
PROBIOTIC EXPERTS
PROBIOTIC EXPERTS
Microbiome Science based solutions supported by robust scientific clinical evidence.
PROBIOTIC SOLUTIONS
PROBIOTIC SOLUTIONS
A portfolio of solutions based on strain specificity, distributed across several international markets.
360º SERVICES
360º SERVICES
End-to-end services, from strain development to final product.
MANUFACTURING
MANUFACTURING
Segregated and controlled facilities in accordance with pharmaceutical standards.
Microbiome Focus Products
Our products have been developed to support the management and improvement of a wide range of conditions.
Giniwa® V
Women health
A natural probiotic solution to restore and maintain vaginal microbiota balance thus promoting intimate health.
Giniwa® U
Women health
A natural probiotic solution to support urinary health and a complementary approach in cystitis management.
Giniwa® M
Women Health
A triple synergistic action to support the well-being of both mother and baby, ensuring protection during pregnancy and breastfeeding.
Flowbiotic®
Gut & Immune Health
The first synbiotic solution with clinically proven strains, prebiotics, rye, and dietary fibre to help reduce constipation symptoms at every stage of life.
Nutralactis®
Gut & Immune Health
A synbiotic solution with probiotics, prebiotics and vitamin C to reinforce the gut and immune health. Customized to every life stage.
Top4U®
Sports performance
A portfolio of probiotic solutions that maximizes aerobic and strength training, customized to each type of training.
Reutopic®
Veterinary
Veterinary solution with postbiotics to help reduce the signs of canine atopic dermatitis. It combines a lotion and shampoo for complementary skin care.
Otibiome
Respiratory Health
A clinically evaluated probiotic approach to help protect against recurrent Acute Otitis Media (AOM) in children.
Pharmalactis® Breathe
Respiratory Health
A triple synergic postbiotic based solution to support the management of respiratory disorders and allergies.
Fertibiome®
Women Health
A clinically evaluated probiotic solution to support fertility in couples, with 89% success in restoring microbial balance.
End-to-End CDMO Pharmaceutical Partner
Zinereo Pharma, as part of the Zendal Group, is positioned as a CDMO specializing in pharmaceutical-grade medicines and probiotics.
ANALYTICAL DEVELOPMENT
PHARMACEUTICAL DEVELOPMENT
MANUFACTURING
DISTRIBUTION
International Expansion
With an established presence in LATAM, MENA, ASIA and AFRICA, we are actively expanding into new international markets to address evolving global health challenges.









